Russell Frank Company’s AngioDynamics ANGO Stock Holding History

Russell Frank Company’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$420K	Buy	34,110 +24,362	+250%	+$269K	﹤0.01%	2511
2015 Q4	$119K	Sell	9,748 -72,858	-88%	-$897K	﹤0.01%	2781
2015 Q3	$1.09M	Buy	82,606 +40,398	+96%	+$610K	﹤0.01%	2158
2015 Q2	$692K	Buy	+42,208	New	+$701K	﹤0.01%	2478
2015 Q1	–	Sell	-66,891	Closed	-$1.28M	–	2971
2014 Q4	$1.28M	Buy	+66,891	New	+$1.13M	﹤0.01%	2012
2014 Q3	–	Sell	-8,029	Closed	-$123K	–	2844
2014 Q2	$123K	Hold	8,029	–	–	﹤0.01%	2620
2014 Q1	$110K	Sell	8,029 -59,519	-88%	-$970K	﹤0.01%	2664
2013 Q4	$1.12M	Buy	67,548 +39,372	+140%	+$606K	﹤0.01%	2018
2013 Q3	$372K	Sell	28,176 -50,574	-64%	-$596K	﹤0.01%	2590
2013 Q2	$888K	Buy	+78,750	New	+$838K	﹤0.01%	2116

Other funds holding ANGO

RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

SAM

Sentinel Asset Management Montpelier, Vermont $868K AUM 45.44% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Russell Frank Company's ANGO Position: Q1 2016 in Review

Russell Frank Company increased its AngioDynamics (ANGO) stake by 250% in Q1 2016, buying an estimated $269K and bringing the position to 34,110 shares worth $420K. The position accounts for ﹤0.01% of the portfolio, ranked #2511.

Russell Frank Company first reported a position in ANGO in Q2 2013 and has held it in 10 quarters since. The position peaked at $1.28M in Q4 2014. 121 funds tracked by Wall St. Rank hold ANGO as of Q1 2016.

Russell Frank Company held 34,110 shares of AngioDynamics worth $420K as of Q1 2016.
Russell Frank Company bought 24,362 AngioDynamics shares in Q1 2016, an estimated $269K.
AngioDynamics made up ﹤0.01% of Russell Frank Company's portfolio in Q1 2016, its #2511 holding.
Russell Frank Company first reported a position in AngioDynamics in Q2 2013 and has held it in 10 quarters since.
Russell Frank Company's AngioDynamics position peaked at $1.28M in Q4 2014.
121 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2016.

Based on Russell Frank Company's 13F filing for Q1 2016, filed 29 Apr 2016.